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Abstract  
Background 
Alcohol use is an important issue among problem drug users. Although screening and brief 
intervention are effective in reducing problem alcohol use in primary care, no research has 
examined this issue among problem drug users.  
Objectives 
To determine if a complex intervention, incorporating screening and brief intervention for 
problem alcohol use among problem drug users, is feasible and acceptable in practice and 
effective in reducing the proportion of patients with problem alcohol use. 
Methods 
PINTA is a pilot feasibility study of a complex intervention comprising screening and brief 
intervention for problem alcohol use among problem drug users with cluster randomisation at the 
level of general practice, integrated qualitative process evaluation, and involving general 
practices in two socioeconomically deprived regions. 
Participants: Practices (N=16) will be eligible to participate if they are registered to prescribe 
methadone and/or at least 10 patients of the practice are currently receiving addiction-treatment. 
Patient inclusion criteria are: aged 18 or over and receiving addiction treatment / care (e.g. 
methadone) or known to be a problem drug user. 
Interventions: A complex intervention, supporting screening and brief intervention for problem 
alcohol use among problem drug users (experimental group) compared to an ‘assessment only’ 
control group. A delayed intervention being available to ‘control’ practices after follow up. 
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Outcome: Primary outcomes are feasibility and acceptability of the intervention to patients and 
professionals. Secondary outcome is the effectiveness of the intervention on care process 
(documented rates of screening and brief intervention) and outcome (proportion of patients with 
problem alcohol use at the follow up). 
Randomisation: Stratified random sampling of general practices based on level of training in 
providing addiction-related care and geographical area. 
Blinding: Single-blinded; GPs and practice staff, researchers and trainers will not be blinded, but 
patients and remote randomisers will.  
Discussion 
This is the first study to examine feasibility and acceptability of primary care based complex 
intervention to enhance alcohol screening and brief intervention among problem drug users. 
Results will inform future research among this high-risk population and guide policy and service 
development locally and internationally. 
Keywords 
Complex intervention, Screening, Brief intervention, Alcohol, Methadone maintenance, Primary 
health care, General practice, Substance-related disorders 
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Introduction  
Problem alcohol use is associated with adverse health and economic outcomes, all the more so 
among problem drug users (e.g. individuals currently using illicit drugs, or trying to abstain from 
other illicit drugs such as benzodiazepines, cocaine or heroin) [1, 2]. Such alcohol use may 
decrease in response to psychosocial interventions whose benefits have been demonstrated in 
general adult populations. For example, a comprehensive review by Raistrick et al presented data 
on the effectiveness of many such interventions, including screening, further assessment, brief 
interventions and alcohol-focussed specialist treatment [3].  
 
Primary care may have an important role in addressing problem alcohol use among problem drug 
users.  Its potential impact on screening for alcohol problems and providing appropriate 
interventions in the general population has been described [4], although a recently published 
randomised trial indicates that more intensive primary care based interventions provide little by 
way of additional benefit to patient information alone[5]. Internationally, screening and brief 
interventions (SBI) are recommended as a treatment of choice for reducing alcohol use among 
problem drinkers in primary care [6, 7], but they have not been tested in people who are addicted 
to other substances and who attend primary care [8]. It is important to address this issue in this 
patient group because of serious complications associated with problem alcohol use in this 
population: i.e. potential to increase the likelihood of a relapse to problem drug use, medical / 
psychological complications, liver disease, etc. [1, 2]. 
 
Similar to other evidence-based interventions, the evidence on SBIs translates into practice 
slowly [9-11], and the findings from implementation studies are contradictory. For example, 
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while a systematic review of interventions focused on increasing the use of screening and brief 
intervention for hazardous alcohol consumption in primary care recommended complex, multi-
component strategies [12], a recent trial concluded that such a ‘tailored, multi-faceted 
programme aimed at improving GP management of alcohol consumption’ failed to show an 
effect and proved difficult to implement[13]. This also contradicts the conclusions of a recent 
paper, that ‘real world evidence supports theory’ of SBIs [14].  
 
More impetus to this contradictory debate has been added by recent implementation studies and a 
controlled trial among problem drug users in secondary care, which demonstrated feasibility of 
implementing screening and brief interventions among problem drug users in secondary care but 
suggested a controlled pilot study was necessary to establish key parameters for a similar 
evaluation in primary care [15-17]. This study is designed to examine these issues. 
 
Previous work in Ireland and how it relates to complex intervention theory 
 
This protocol builds on our on-going programme of research which indicates (opiate) addiction 
treatment should also incorporate interventions that address problem use of alcohol and other 
illicit substances. For example, a national cross sectional study reported 35% of patients 
attending GPs for methadone treatment also had problem alcohol use [18] while findings from a 
subsequent qualitative study highlight the need for a complex intervention to address this 
problem in primary care [19].  
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The UK Medical Research Council (MRC) ‘Framework for the Development and Evaluation of 
Complex Interventions for Randomised Controlled Trials (RCT)’ [20] , which suggests core 
phases to the development of complex health services interventions, informed the development 
of the intervention under study .  
 
(1) Preclinical phase: Theory and problem identification 
- A national prevalence study showed problem alcohol use among was high (35%) among 
patients attending general practice for methadone maintenance[18] 
- A review of scientific evidence found no studies examining this issue in primary care but 
research in secondary / community care settings suggests this type of intervention can be 
effective among problem drug users[21] 
 
(2) Phase 1: Modelling 
Development of a complex intervention / clinical guidelines informed by: 
 Cochrane Systematic review on ‘Psychosocial interventions for problem alcohol use in 
illicit drug users’[8] 
 Qualitative interviews with healthcare providers and patients, which found that barriers to 
implementation of alcohol intervention for drug users in primary care include: Patient 
factors, Healthcare professional factors and Structural issues; the implementation 
strategies should utilize educational and support systems [19] 
 Clinical guidelines, informed by the findings of qualitative interviews, expert opinion 
through a Delphi-facilitated expert consensus process and a Cochrane Systematic 
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Review[8], advocate screening and brief intervention (SBI) for problem alcohol use 
among problem drug users.  
 
 
(3) Phase 2: Exploratory study 
- A pilot study in addiction clinics showed that SBIs are effective in reducing alcohol 
consumption among opiate dependent patients[16] 
- Current proposal to establish the acceptability and effectiveness of the intervention by 
conducting a feasibility study in primary care. 
 
This protocol reflects the development and piloting phases of the MRC ‘Framework for design 
and evaluation of complex interventions to improve health’ [20, 22]. The study will provide key 
parameters regarding the feasibility and acceptability of the intervention to patients and 
practitioners. As such, this research is essential to inform the design and conduct of a larger 
cluster randomised controlled trial.  
Specific objectives:  
 To develop a complex-intervention which will enhance screening and brief intervention 
for problem alcohol use among problem drug users in primary care; 
 To establish the feasibility and acceptability of this intervention in practice, by 
o Conducting a pilot study (with randomisation at the level of practice); 
o Exploring the feasibility and acceptability of the intervention under study and 
related research procedures to GPs, practice nurses and patients; 
o Exploring the fidelity of the interventions as delivered in practice; 
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 To inform the subsequent design of a definitive cluster randomised controlled trial, by 
o Describing the optimum configuration of the complex intervention;  
o Estimating the key parameters in such a trial (i.e., practice / patient recruitment 
and retention rates, intraclass correlation coefficient for primary outcome 
measures and the likely effect of intervention under study on these measures). 
Methods  
Overview of study design  
Pilot feasibility study of a complex intervention to promote screening and brief intervention for 
problem alcohol use among problem drug users, with cluster randomisation at the level of 
general practice, and integrated qualitative process evaluation, involving general practice in two 
regions. 
 
Study population 
Recruitment and random selection of practices  
The following practices will be invited to participate, given written information on the study and 
asked to indicate their interest in participating:  
 All practices in two regions – Health Services Executive (HSE) Midwest and Dublin 
Mid-Leinster regions, and 
 All practices who have been involved in previous related research with our group [18, 23-
29] 
 General practices in the study regions who are affiliated with two of Ireland’s six medical 
schools [30, 31] 
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Practices will be eligible to participate if they are registered to prescribe methadone, and/or have 
at least 10 patients currently receiving addiction-related care. 
 
Of those who confirm their interest in the study and who are eligible to participate, a stratified 
random sampling technique will be used to select 16 practices.  
Sampled GPs will be contacted about their participation, given further information on the study 
(e.g., what their involvement will entail) and consulted about patient recruitment. The research 
team will telephone those not replying. Each practice will be visited by the principal investigator 
/ lead researcher and provided with information about the research programme. 
 
To ensure comparability between intervention and control groups for key practice characteristics, 
a restricted allocation involving stratified approach to randomisation will be adopted. Prior to 
randomisation, those GPs who express an interest in participating will be grouped according to 
level of training in providing addiction related care (level 1, 2), geographical location (Dublin/ 
Midwest), with 16 randomly selected using an independent remote randomisation service.  
To prescribe methadone, GPs are subject to clinical audit and must complete special training, 
with GPs providing methadone treatment for 15 or more patients subject to more regular audit 
and advanced training. GPs who prescribe methadone for less than 15 patients are referred to as 
‘level one GPs,’ and those prescribing for 15 or more as ‘level two’ GPs. Initiation of methadone 
therapy, treatment of patients with more complex medical and psychosocial needs (including 
alcohol dependence) and unstable drug use is only permitted by specialist addiction treatment 
services or by ‘level two’ GPs. A more complex, difficult cohort of patients attends level two 
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GPs and this might have implications for the success of the intervention. Therefore, it will be 
introduced in the data analysis as a potential confounder. 
 
 
Identification and recruitment of patients 
Before introducing the complex intervention, each participating practice will engage in an 
intensive, two-week period of patient recruitment, an approach we found most effective in 
previous qualitative work with this population [19].This two-week period will be supported by a 
member of the research team and will aim to: a) establish a ‘disease’ register of patients, b) 
obtain contact details for and informed consent from eligible patients, c) review the clinical 
records of patients who consent to participate in the study and d) collect baseline data, including 
patient demographics and current care process / outcome measures from clinical records. 
Patients will be eligible to participate if they are: aged 18 or over, receiving addiction treatment 
/care (e.g., methadone), or known problem drug user, and attending a participating general 
practice for general medical care. They will be excluded from the study if they have language 
difficulties (i.e., unable to speak, read and write English sufficiently well to complete study 
questionnaires), are acutely intoxicated, and / or are cognitively impaired (including severe 
mental health illness) to the extent that they are unable to provide informed consent to 
participate. 
 
Systematic random sampling of patients in participating practices is difficult in studies among 
this population [25]. Hence, a standardised non-probability sampling framework will be used to 
identify consecutive patients from each practice on whom data will be collected for the purpose 
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of the study. Potential patient selection bias will be assessed in the exploratory data analysis, by 
comparing the socio-demographics of the included patients with all patients, who were identified 
as problem drug users, in each practice. 
 
Patients who consult a GP taking part in the study, and who in the clinical opinion of the GP are 
eligible for the study (see inclusion criteria above), will be given written information on the 
study. Those interested in participating will be invited to meet a researcher who will be at the 
practice during the recruitment period. At this meeting, interested patients will be given further 
information on the study and will have an opportunity to ask the researcher questions. If they 
consent to participate, patients will be asked to sign a consent form and to complete a self-/ 
interviewer-administered questionnaire that includes problem alcohol use and other outcome 
measures, if necessary with the assistance of the researcher at T1 (i.e., Time 1, at baseline) and 
T2 (i.e., Time 2, at three months follow up). This applies to patients in both intervention and 
control groups. 
Following completion of the self-/ interviewer-administered questionnaire with the researcher, 
patients in the intervention practices will be screened for problem alcohol use and delivered the 
brief intervention by their GP/ practice team (at their earliest convenience). Patients in the 
control arm will receive the ‘Less is more’ leaflet (A guide to rethinking your drinking, Health 
Service Executive, 2008) from the researcher. A “thank you” letter will be sent to all GPs and 
patients within two weeks of receiving completed study instruments/ intervention. A reminder 
letter will be sent to all GPs and patients five weeks before the follow-up assessments informing 
them of the anticipated time/date of their appraisal. Participant flow and follow up is outlined in 
the CONSORT diagram [32], Figure 1. 
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Figure 1 CONSORT diagram - Participant flow and follow up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Eligible practices invited to the study 
Practices agreed to participate in study 
No further 
action 
8 Practices randomised to 
‘INTERVENTION’ arm 
8 Practices randomised to 
‘CONTROL’ arm 
Enrollment Enrollment 
No further 
action 
No further 
action 
Baseline assessment Baseline assessment 
Screening AUDIT Screening AUDIT NEGATIVE, 
Follow-up 
NEGATIVE, 
PIL 
POSITIVE POSITIVE 
CONTACT DETAILS + MAP + RULER 
BI / Referral as p/ guide 
3 MONTH FOLLOW 
UP AUDIT, MAP, 
RULER, SAAPQ 
(staff) 
NO 
Yes 
NO NO 
Yes 
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Power calculations and sample size estimates 
The goals of this study are to examine feasibility, acceptability and effectiveness of the complex 
intervention. With respect to the feasibility component, the study aims to achieve the following 
rates of recruitment/ consent, participation and retention, as observed in previous studies cited 
below: 
 20% recruitment rate defined as number of invited GPs who confirm their interest in the 
study [19], 
 75% participation rate, i.e., number of participants allocated to the intervention arm who 
will receive/ complete screening and brief intervention [5], 
 75% retention/ follow-up rate [5]. 
 
Based on the recommendations for good practice in pilot studies [33, 34], we estimate that 160 
patients (attending 16 general practices) will be adequate to calculate the actual recruitment and 
retention rates (i.e., feasibility) for a sample of patients recruited in primary care and provide data 
on acceptability of study processes and outcome measures which will inform a future definitive 
trial. This pilot study is not powered to determine effectiveness of SBI on reduction of alcohol 
consumption among problem drug users. The proportion of patients who reduce their alcohol 
consumption will be used to predict the sample size and length of follow up for a future 
definitive RCT. 
 
Intervention 
A staggered intervention design will be adopted, whereby participating practices randomised to 
the intervention arm of the study will be provided with the complex intervention for the duration 
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of the study period, while practices randomised to the control arm of the study will provide usual 
care to patients for the duration of the study and provided with the complex intervention 
thereafter (i.e. delayed intervention). Such an approach was successfully used in our previous 
cluster randomised controlled study to improve screening for hepatitis C among problem drug 
users attending general practice in Ireland [25].  
 
Control intervention 
 
All practices (control and intervention arms) will be required to:  
- Establish a ‘disease’ register of ‘problem drug users’ before study onset; 
- Identify potential participants for the study;  
- Recruit participants for the study / obtain informed consent;  
- Enable interview with a member of the research team (telephone or in-person) to determine 
problem alcohol and other drug use, demographic details at baseline and at three months 
follow up; 
- Facilitate data collection (including morbidity, primary / secondary care utilisation) from 
clinical records by researchers; 
- €50 per patient recruited to study (paid to the GP upon receipt of completed data)[35]. 
We consider the above engagement with practices as close to 'usual care' as possible while still 
allowing evaluation of the complex intervention. To enable the development of a practice 
register of people with problem drug use, clinical records and prescribing information will be 
reviewed. For those practices who use electronic patient records, an International Classification 
of Primary Care (ICPC) disease code (P19) will be assigned to those patients who meet the 
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criteria of Europe’s Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for ‘Problem 
Drug Use’. For those practices that use paper records, this register will be developed in hard 
copy.  
 
Experimental intervention 
A complex intervention will be delivered to practices assigned to the intervention arm and this 
will be delivered at two levels, practice level and patient level. 
Practice level: 
i. CME / CPD accredited education delivered both internally (practice-based academic 
detailing) and externally (seminar) 
ii. Dissemination of clinical guidelines  
iii. Other resources to facilitate implementation at practice level (e.g., contact details / 
referral information for local services) 
All practices will participate in the external education (seminar). Internal education (practice-
based academic detailing) will be offered on as needed basis, depending on practice resources 
and experience with SBI[36]. Academic detailing and support will be available to practices 
during the three months study period. The number and duration of these visits will be used to 
predict the level of support for a future definitive RCT. 
Patient level: Delivery of SBI (10-15 minutes) to patients. 
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Data collection 
At baseline, demographic details and data on primary/secondary outcome measures will be 
collected by reviewing clinical records and by patients completing study instruments.  
At follow up, data will again be collected by reviewing clinical records and by patients 
completing study instruments. Participants will be invited to complete a follow up interview with 
a researcher to include primary / secondary outcome measures. A purposive sample of patients in 
the ‘intervention’ arm will be interviewed regarding their experience of problem alcohol use 
related care in the preceding three months.  
 
Quantitative data will be collected at baseline (T1) and at three months follow up (T2):  
 Review of clinical records (T1, T2), 
 Self or interviewer - administered questionnaires and semi-structured interviews 
(patients, T1, T2), 
 Self-administered questionnaires, incl. open-ended questions (practitioners, T2). 
 
Outcome measures 
Table 1 summarises the key data being collected during the study.  
Table 1 Primary and secondary outcome measures to be used at the baseline and /or 
follow-up examinations 
 
Aim / 
Target group 
Patient measures Staff and organisation measures System measures 
1) Feasibility Indirect (review of clinical 
records):   
 Socio-demographic 
characteristics and general 
medical morbidity (i.e. 
clinical records review 
Self-administered baseline 
questionnaire to include: 
 Practice / professional details, 
 Experience of training, 
 Adherence to intervention 
guide / manual assessed with 
Indirect (review of clinical 
records): 
 Current and previous practice, 
with regards to screening and 
intervention for problem 
alcohol use among identified 
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using a structured 
instrument previously 
developed previously[24]) 
at baseline 
 
the NIH ‘Behaviour Change 
Framework’[37] (includes five 
intervention adherence 
strategies: Intervention design, 
Training procedures, Delivery 
of intervention, Receipt of 
intervention, and Enactment of 
SBI skills) at follow up 
 SAAPPQ questionnaire – see 
below 
 
problem drug users, i.e.: 
 Numbers of patients who were 
a) screened for alcohol, b) 
offered a brief intervention, c) 
received the brief intervention, 
d) referred to a specialist at 
follow up 
 
2) Acceptability  Patients’ experience of 
intervention: semi-
structured interviews at 
follow up ( via telephone or 
face to face) 
Postal survey to include: 
 Shortened Alcohol and 
Alcohol Problems Perception 
Questionnaire (SAAPPQ)[38] 
at baseline and follow up 
 Healthcare professionals’ 
experience of the intervention: 
Free text in questionnaires at 
follow up eliciting information 
on staff attitudes towards 
alcohol screening and brief 
intervention; previous practice 
of alcohol screening and brief 
intervention; preparedness to 
undertake these activities; the 
training required to implement 
screening and brief 
intervention; the suitability of 
each site to provide SBI[35]. 
Postal survey examining: 
 perceived barriers or enablers 
of implementation of SBIs in 
Ireland. 
3) Effectiveness Direct (interview at baseline 
and follow up):  
 AUDIT [39] 
 Other drug use (e.g., 
Maudsley Addiction Profile 
[40]) 
 Motivation to change risky 
behaviour (e.g., Readiness 
ruler [41]). 
 
 Indirect (review of clinical 
records):   
 
 Results of chemical tests for 
alcohol and drugs (e.g., 
breathalyser or urine tests) will 
be also retrieved using the 
practice records to verify self-
report measures. 
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a) Staff and organisation measures: 
Healthcare professionals at participating practices will be asked to complete a self-administered 
questionnaire which will elicit data on:  
- Practice / professional details 
- Experience of training  
- Intervention fidelity. The NIH ‘Behaviour Change Framework’ [37]. 
- Shortened Alcohol and Alcohol Problems Perceptions Questionnaire (SAAPQ). 
b)  System measures: 
1) total number of patients screened for alcohol problems (and method of screening), 2) the 
number screening positive, 
4) the number receiving any alcohol intervention (including referral), 
3) results of chemical tests for alcohol and drugs (e.g., breathalyser or urine tests) conducted by 
GPs will be also retrieved using the practice records (T2) to verify self-report measures.  
c) Patient measures: 
 Indirect examination, 
 Direct examination. At baseline and follow up, the study battery will include the 
following: 
 
AUDIT-  Alcohol use disorders identification test (10 items), developed by the World Health 
Organisation to identify a continuum of problem alcohol use [21, 39]. 
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Maudsley Addiction Profile (MAP) a brief, structured questionnaire for treatment outcome 
research, which measures problems in four areas: substance use, health risk behaviour, physical 
and psychological health, and personal/social functioning [18, 40]. 
 
Readiness Ruler will assess patient’s motivational state regarding changing their drinking 
behaviour [42]. 
Financial incentives 
Participating practices will be offered €50 per patient to compensate for the extra administration 
work as in a similar trial [35]. We consider this a conservative level of remuneration given the 
additional work involved for participating practices [43]. 
 
Data analysis 
Descriptive statistics will be estimated with respect to key feasibility variables:  
 Baseline:  
o Practice recruitment rate 
o Prevalence of problem drug use at participating practices  
o Patient recruitment rate 
o Baseline prevalence of problem alcohol use among problem drug users 
 Intervention: process and fidelity evaluation of pilot educational intervention; 
 Outcome:  
o Practice / patient retention rates 
o Prevalence of problem alcohol use among problem drug users 
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o Confounding factors, e.g. practice busyness or person who did SBI 
 
SPSS v20 and R software will be used for analysis by the HRB Centre for Support and Training 
in Analysis and Research. 
 
Qualitative evaluation 
A parallel qualitative evaluation will also be conducted with patients and healthcare 
professionals:  
 
With regard to healthcare professionals, open-ended questions eliciting information on staff 
attitudes towards alcohol screening and brief intervention; previous practice of alcohol screening 
and brief intervention; preparedness to undertake these activities; the training required to 
implement screening and brief intervention; the suitability of each site to provide SBI; and other 
barriers to effective implementation[35]. 
With regard to patients, among a 20% purposive sample (estimated N=16) of patients in the 
intervention practices, we will also explore patients’ satisfaction with and experience of 
intervention and problem alcohol use related care in the preceding 3-6 months. Interviews will be 
done by researcher via telephone, postal questionnaire or in person. Prior to the interviews, the 
participant will be informed of the interview purpose, the interview procedure and the use of the 
findings. The participant will then be invited to sign an additional consent form and the interview 
will commence.  
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Qualitative data analysis will be systematic and organised in order to easily locate information 
within the data set when tracing results, providing examples in context[44]. The qualitative 
research software Nvivo v8 will be used to facilitate the coding. Thematic analysis will be used 
to analyse qualitative data. This approach has many benefits for studies such as this which are 
interpretive in nature, as it is a ‘method for identifying, analysing and reporting patterns (themes) 
within data’[44]. 
Ethical considerations  
Ethical approval has been obtained from the Research Ethics Committee of the Irish College of 
General Practitioners (Protocol Reference: Cullen, November 29
th
, 2012). Research carried out 
on humans in this study is in compliance with the Helsinki Declaration. The protocol follows the 
CHECKLIST of items to consider for inclusion in a report of a pilot studies[45], adopted from 
the CONSORT statement [32, 46]. 
A two-stage procedure to obtain informed patient consent to participate in the study will be used 
during the study. Patients who consult a GP taking part in the study, and who in the clinical 
opinion of the GP are eligible for the study, will be given written information on the study (brief 
study information sheet). Those interested in participating will be invited to meet a researcher 
who will be at the practice during the recruitment period. At this meeting, interested patients will 
be given further information on the study and will have an opportunity to ask the researcher 
questions. When all issues have been explained to the person’s satisfaction, he or she will be 
asked to indicate consent to participate in the study by signing a consent form and this procedure 
will be witnessed by a third party. The standard patient consent form for participation in non-
clinical trials, developed by the Research Ethics Committee of the Irish College of General 
Practitioners, will be used in the study. Participation in the study will be on a voluntary basis. No 
Page 22 
inducements to participate will be offered to patients, and refusal to participate will not 
compromise patient care.  
 
Potential adverse effects of the intervention will be explored in the qualitative interviews with 
patients and practitioners.  
 
Discussion 
The PINTA is the first study to examine the feasibility and acceptability of alcohol screening and 
brief intervention for problem alcohol use among problem drug users attending primary care. It 
will provide key data which will enhance scientific understanding of interventions that prevent 
risk behaviours, inform policy and service development and contribute to health and social gain 
locally and internationally. 
 
The project team involves academic, clinical, policy experts responsible for planning/delivery of 
addiction care/primary care and international experts on optimum primary care delivery to at-risk 
populations / primary care alcohol treatment.  
The proposed work will build on our recently completed project which has identified problem 
alcohol use as a common finding among patients on methadone and subsequent programme of 
research which has explored and documented existing practices with respect to alcohol 
interventions among this group. This information is used, in conjunction with scientific evidence, 
to develop clinical guidelines regarding screening and treatment for problem alcohol use, and 
then consult it with patients / healthcare professionals.  
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At the end of this research, the feasibility of a clinical intervention, informed by international 
best practice and local barriers, will be evaluated in areas of high need. This intervention is likely 
to consist of a training and support programme and clinical guidelines. By involving service 
users and service providers in their development phase, acceptability and feasibility will be 
enhanced. The research methodology also gives a voice to a group of service users not normally 
at the centre of how interventions are tested. 
This feasibility study may inform clinical practice by providing initial indications as to whether 
psychosocial interventions for problem alcohol use are feasible, acceptable and also effective 
among problem drug users attending primary care. It will also inform future research on the topic 
by providing key parameters for the design of a future cluster randomised controlled trial. 
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